Scarica l'app Stockscreener
10.25
12.02%
1.10
Dopo l'orario di chiusura:
10.25
Precedente Chiudi:
$9.15
Aprire:
$9.24
Volume 24 ore:
221.41K
Relative Volume:
0.40
Capitalizzazione di mercato:
$27.78M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+12.95%
1M Prestazione:
+64.26%
6M Prestazione:
+98.64%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$9.24
$10.37
Intervallo di 1 settimana:
$7.961
$10.37
Portata 52W:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Confronta QNTM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
10.25 | 2.61M | 0 | 0 | 0 | 0.00 |
|
HLN
Haleon Plc Adr
|
10.80 | 47.63B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
163.04 | 71.99B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.85 | 3.50M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.11 | 44.91B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.94 | 20.73B | 16.54B | -1.64B | 749.00M | -1.45 |
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
Quantum BioPharma to Present at Upcoming Investor Conferences - TipRanks
Cathie Wood Is Betting Big on This Hidden-Gem AI Stock - The Globe and Mail
Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference - GlobeNewswire
Quantum BioPharma Sets Double Conference Appearance: Key Investor Presentations Coming This May - Stock Titan
Prediction: MercadoLibre Will Beat the Market. Here's Why. - The Globe and Mail
TORONTO TEMPO MARKS ONE YEAR TO TIP-OFF WITH IMMERSIVE TEMPO LIVE EVENT - The Globe and Mail
Quantum Biopharma reports Q1 2025 financials - Investing.com
Quantum Biopharma reports Q1 2025 financials By Investing.com - Investing.com Nigeria
Quantum Biopharma Reports Q1 2025 Financial Results - TipRanks
Quantum BioPharma (QNTM) Completes Key Studies for Multiple Scle - GuruFocus
Quantum BioPharma Completes Key Studies for MS Drug Lucid-MS - TipRanks
Quantum BioPharma Completes Dosing in 90-Day Toxicity Studies for Multiple Sclerosis Drug Lucid-21-302, Advancing Toward IND Submission - Nasdaq
Quantum BioPharma Announces Completion of Dosing in 90-Day - GlobeNewswire
Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis - Welland Tribune
Quantum BioPharma Ltd. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:QNTM) - Seeking Alpha
Quantum Biopharma Files Amended Complaint Against CIBC - GlobeNewswire
Quantum BioPharma (QNTM) Files Amended Complaint Over Alleged Ma - GuruFocus
Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - The Manila Times
Atlassian Q3 Earnings Surpass Expectations, Revenues Rise Y/Y - The Globe and Mail
Quantum Biopharma Ltd. Approved to Dual List on Upstream - ACCESS Newswire
Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Quantum BioPharma to Reveal Year-End Results and Key Regulatory Milestones in May 6 Update - Stock Titan
Quantum BioPharma Ltd. to Host Business Update Conference Call on May 6, 2025 - Nasdaq
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time - GlobeNewswire
Quantum BioPharma adds Kevin Malone as advisor - Investing.com Australia
Quantum BioPharma adds Kevin Malone as advisor By Investing.com - Investing.com South Africa
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor - The Manila Times
Quantum Biopharma Announces Advocate Against Naked Short - GlobeNewswire
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin ... - Bluefield Daily Telegraph
Quantum BioPharma Strengthens Defense: Short Selling Expert Kevin Malone to Combat Market Manipulation - Stock Titan
Quantum BioPharma Announces RSU Grant and Debt Settlement - TipRanks
Quantum BioPharma Corporate Update - Newsfile
1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ - The Globe and Mail
West Fraser Timber Ltd Stock Analysis: Q1 2025 Earnings and Future Outlook - The Globe and Mail
Meta Platforms (META) Can Withstand an Advertising Slowdown, Says Citigroup - The Globe and Mail
Stocks Pressured by Fears of a Tariff-Induced Slowdown - The Globe and Mail
Why ServiceNow Stock Is Gaining Today - The Globe and Mail
What to Know About Jeff Bezos’ Secret EV Startup Slate Auto - The Globe and Mail
Allied Announces April 2025 Distribution - The Globe and Mail
Rocket Lab Stock (RKLB) Soars on Major Hypersonic Tech Deals with US and UK Governments - The Globe and Mail
Abbott Laboratories (ABT) Q1 Earnings: What To Expect - The Globe and Mail
BWXT Moving Forward to Support National Security, Domestic Uranium Enrichment Mission - The Globe and Mail
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhar - GuruFocus
Quantum BioPharma (QNTM) Prevails in Legal Dispute with Former C - GuruFocus
Lithium Argentina to Release First Quarter 2025 Results on May 14, 2025 - The Globe and Mail
Quantum BioPharma wins legal battle against former CEO By Investing.com - Investing.com South Africa
Market Analysis: April 14th, 2025 - The Globe and Mail
Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold - The Globe and Mail
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Canadian Insurance Market Remains Strong Amidst Market Volatility: Aon Report - The Globe and Mail
Quantum Biopharma Ltd Azioni (QNTM) Dati Finanziari
Non sono disponibili dati finanziari per Quantum Biopharma Ltd (QNTM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):